A vaccine against nicotine for smoking cessation: a randomized controlled trial
about
Nicotine vaccines for smoking cessationCrystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamineMechanistic insights into nicotine withdrawal.Virus-Based Nanoparticles as Versatile NanomachinesPhage display as a promising approach for vaccine developmentBiologic Approaches to Treat Substance-Use DisordersNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Versatile virus-like particle carrier for epitope based vaccinesEnhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)Treatment of nicotine addiction: present therapeutic options and pipeline developments.Evaluation of a screening and counseling tool for alcohol misuse: a Virginia Practice Support and Research Network (VaPSRN) trialAddressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programsNicotinic Receptors: Role in Addiction and Other Disorders of the Brain.New directions in nicotine vaccine design and use.Nicotine vaccines: will smokers take a shot at quitting?Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.Subviral particle as vaccine and vaccine platform.Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeuticHapten optimization for cocaine vaccine with improved cocaine recognitionCocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.Pharmacological intervention of nicotine dependence.High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuseScientific overview: 2013 BBC plenary symposium on tobacco addiction.RNA-directed packaging of enzymes within virus-like particles.Impact of distinct chemical structures for the development of a methamphetamine vaccineTargeting nicotine addiction: the possibility of a therapeutic vaccine.Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceAn update on the use of laser technology in skin vaccination.Bacterially produced recombinant influenza vaccines based on virus-like particles.Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditionsInsights into scFv:drug binding using the molecular dynamics simulation and free energy calculation.Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.A conjugate vaccine attenuates morphine- and heroin-induced behavior in ratsAnti-addiction vaccines.Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategyAdjuvants for vaccines to drugs of abuse and addiction.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform
P2860
Q24201422-915BEE81-CFF1-44A6-A48B-77E1C2D12C0CQ27657455-A1C3BD00-5830-45CC-B696-23A8AA51A800Q27687645-F5C1E3D7-2F06-41B2-A254-5E0147DA43A8Q28068538-33FBF666-A433-4EC5-A5B7-BBF286CACFC0Q28074592-B24A920D-1CCE-452E-8DDF-CF1804591942Q28085073-AF6FF82E-53B0-4B1B-B4C3-23C27B85729EQ28277165-F1E0A314-1FF7-439D-8B8A-81B7997E769BQ28748358-C3B95D6D-1566-4D82-BB9F-186E6E90573FQ30355360-0DBA6F9C-09B1-4999-811A-19040B4CCC43Q30361416-9CDD5F13-2145-4493-86C5-D6765C3859AAQ30392892-22B9A89F-590B-46C4-B09C-77C7DE672F77Q30398847-F6235533-1629-4FC0-BEE0-26D7BFE0BE51Q30423238-09B7ED0E-E49D-4317-AAA8-7F7A5ECDA5F5Q30477221-DC6E9801-AC2C-4B87-A88C-6253A5987A36Q33635666-B4E6DA83-FB76-4385-AA2C-CA5D45D70591Q33719424-3E98E49E-5024-486C-9A92-ABBD1BC11EAEQ33759617-B0705507-D883-46BB-8F9B-FBF136221434Q33812439-E7E36BF6-33C0-4E2C-8A79-C9CAB6EACE10Q33812653-E2E481E4-1729-4143-BCEA-3BC332380895Q33932923-9D5EE1C1-4BC5-4FB1-B7C9-3F5CD7DB4EDBQ34021922-D8E4A18C-169C-443E-8385-D661E4CF3CC2Q34157554-4D6DE99D-D627-4B09-B96B-6ED9C36991A3Q34401794-1D70FFC3-D6C4-4649-A932-DA0CB2A7D6B1Q34466125-B522F095-C8AB-4DB3-8A48-C8681C3E58CAQ34476304-3A599035-8CE9-4EAA-9180-C4066D10467DQ34487271-54072989-2E36-4701-BAE9-1F8FD239A5C5Q34698687-A434FD62-2578-4C88-A518-E55D69F85390Q34956542-D709452D-C086-48C6-8E72-7797541C2572Q34987300-85672973-695F-4B31-B448-284F75FE6BC9Q35009554-38C8CFAF-B90F-4023-A42E-48EA4DE5F2BBQ35017651-9E640496-7A2B-4705-B63E-58ACF2BADAE0Q35048127-48735A21-CD5F-49FE-A051-8834CDDD6E0DQ35061547-6AC3E813-A60A-4FCC-A28E-4AC7EB6D6FCAQ35129792-484C74F2-C7CD-474B-B461-4FF4E5613796Q35163178-69D82FE1-267D-4F40-8D63-40CA48B6D7D9Q35224297-3D6D217F-233C-4FB2-A3AB-678E47A4BF0DQ35263981-A6EE5F69-C050-49BA-A9D6-32D32FF3BA4FQ35476326-BAC74E02-B7D4-42D6-9B62-2DF0FDB9645AQ35493923-59F5BBB5-BA72-405E-AAE9-DCB4103F79C7Q35591551-81AEB339-9863-429A-9015-1048CAC3A3B7
P2860
A vaccine against nicotine for smoking cessation: a randomized controlled trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@ast
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@en
type
label
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@ast
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@en
prefLabel
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@ast
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@en
P2093
P2860
P1433
P1476
A vaccine against nicotine for smoking cessation: a randomized controlled trial
@en
P2093
Guy van Melle
Joseph Osterwalder
Jörg Willers
Karl Klingler
Martin F Bachmann
Patrik Maurer
Philipp Müller
Susanne Zwahlen
Thomas Cerny
Walter Felix Jungi
P2860
P356
10.1371/JOURNAL.PONE.0002547
P407
P577
2008-06-25T00:00:00Z